ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Peng Nan

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2022: 1 paper

Papers 1

Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin αvβ3/CD36-mediated activation of the MAPK pathway. Co-author DOI 10.1016/j.canlet.2021.12.025 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xiu Rong Dong · 1 shared paper, 2022 · strength 0.17
- Paper Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin αvβ3/CD36-m… DOI 10.1016/j.canlet.2021.12.025 ↗
Haizhen Lu · 1 shared paper, 2022 · strength 0.17
- Paper Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin αvβ3/CD36-m… DOI 10.1016/j.canlet.2021.12.025 ↗
Xiaohang Zhao · 1 shared paper, 2022 · strength 0.17
- Paper Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin αvβ3/CD36-m… DOI 10.1016/j.canlet.2021.12.025 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.